LBI-HTA - Publications - Search - Subject: WB 60 Bioethics. Clinical ethics. Clinical ethics committees
Number of items at this level: 13.

Fried, A. and Wild, C. (2016): Involvement of Citizens and Patients in HTA-Processes – International Experiences and Good Practice Examples. HTA-Projektbericht 86.

Galician Agency for Health Technology Assessment (avalia-t), EUnetHTA and Regione Emilia Romagna (RER), EUnetHTA (2018): Screening for fetal trisomies 21, 18 and 13 by non-invasive prenatal testing (NIPT). EUnetHTA-Report. HTA-Projektbericht 103.

Jonas, S. (2004): [Genetic testing. Editorial]. HTA-Newsletter 31: 1.

Mikl, M. and Wild, C. and Torgersen, H. (1995): [Genetic analysis: Practice of diagnosis and counseling in Austria]. ITA-Projektberichte.

Stanak, M. and Hawlik, K. (2017): Perinatal Care at the threshold of viability Part II: Decision-making at the threshold of viability and ethical challenges at Neonatal Intensive Care Units (NICUs). HTA-Projektbericht 97b.

Wild, C. (2012): Avastin for Age-related Macular-Degeneration. Evidence synthesis after CATT, IVAN, MANTA. Rapid Assessment 005.

Wild, C. (2008): Polymorphism-screening: genetic testing for predisposition - guidance for technology assessment. Poiesis & Praxis: International Journal of Ethics of Science and Technology Assessment 05 (01): 1-14.

Wild, C. (2006): [Tube feeding in the demented elderly]. HTA-Newsletter 44: 4.

Wild, C. (2005): [Statement of the Viennese Bioethics Commission on advance directives. Editorial]. HTA-Newsletter 41: 1.

Wild, C. (2005): [Advance directives: Comment of the Viennese Bioethics Commission]. ITA-Newsletter September 2005: 12-13.

Wild, C. (2001): [Stem cell research, quo vadis? Editorial]. HTA-Newsletter 03: 1-2.

Wild, C. (2001): [Stem cells: Quo vadis?]. ITA-Newsletter September 2001: 8-9.

Wild, C. and Mikl, M. (1996): [Medical genetics in Austria: Opportunities and risks]. Soziale Technik (3): 6-8.

This list was generated on Sat May 26 17:00:29 2018 CEST.